Lv41
460 积分 2022-07-13 加入
Control of adaptive immunity by pattern recognition receptors
1小时前
已完结
The NLR family of innate immune and cell death sensors
1小时前
已完结
Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer
2小时前
已完结
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
11天前
已完结
Recent advances in the treatment of IBD: Targets, mechanisms and related therapies
11天前
已完结
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
13天前
已完结
Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study
13天前
已完结
Precision engineering of antibodies: A review of modification and design in the Fab region
17天前
已完结
The many regulators of epithelial−mesenchymal transition
24天前
已完结
TNF and TNF receptors as therapeutic targets for rheumatic diseases and beyond
27天前
已完结
皖公网安备34019202002308
